Login / Signup

Immune-Mediated Pathogenesis in Dengue Virus Infection.

Arshi KhanamHector Gutiérrez-BarbosaKirsten E LykeJoel V Chua
Published in: Viruses (2022)
Dengue virus (DENV) infection is one of the major public health concerns around the globe, especially in the tropical regions of the world that contribute to 75% percent of dengue cases. While the majority of DENV infections are mild or asymptomatic, approximately 5% of the cases develop a severe form of the disease that is mainly attributed to sequential infection with different DENV serotypes. The severity of dengue depends on many immunopathogenic mechanisms involving both viral and host factors. Emerging evidence implicates an impaired immune response as contributing to disease progression and severity by restricting viral clearance and inducing severe inflammation, subsequently leading to dengue hemorrhagic fever and dengue shock syndrome. Moreover, the ability of DENV to infect a wide variety of immune cells, including monocytes, macrophages, dendritic cells, mast cells, and T and B cells, further dysregulates the antiviral functions of these cells, resulting in viral dissemination. Although several risk factors associated with disease progression have been proposed, gaps persist in the understanding of the disease pathogenesis and further investigations are warranted. In this review, we discuss known mechanisms of DENV-mediated immunopathogenesis and its association with disease progression and severity.
Keyphrases
  • dengue virus
  • zika virus
  • dendritic cells
  • aedes aegypti
  • immune response
  • public health
  • sars cov
  • induced apoptosis
  • oxidative stress
  • early onset
  • climate change
  • regulatory t cells
  • cell proliferation
  • drug induced